Sa Rang Kim

Sa Rang Kim

Auto-generated profile, based on publicly available information

Sa Rang Kim

Department of Dermatology Yale School of Medicine New Haven Connecticut USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2019 in The Gerontologist
Verified
Journal Article
Open access
SSSerena Sabatini
Serena Sabatini
BSBarbora Silarova
Barbora Silarova
AMAnthony Martyr
Anthony Martyr
RCRachel Collins
Rachel Collins
CBClive Mr. Ballard
Clive Mr. Ballard
LCLinda Clare
Linda Clare
Background and Objectives: This systematic review aimed to synthesize and quantify the associations of awareness of age-related change (AARC) with emotional well-being, physical well-being, and cognitive functioning. Research Design and Methods: We conducted a systematic review with a correlational random effects meta-analysis. We included quantitative studies, published from January 1, 2009 to October 3, 2018, exploring associations between AARC and one or more of the following outcomes: emotional well-being, physical well-being, and cognitive functioning. We assessed heterogeneity (I2) and publication bias. Results: We included 12 studies in the review, 9 exploring the association between AARC and emotional well-being and 11 exploring the association between AARC and physical well-being. No study explored the association between AARC and cognitive functioning. Six articles were included in the meta-analysis. We found a moderate association between a higher level of AARC gains and better emotional well-being (r = .33; 95% CI 0.18, 0.47; p <.001; I2 = 76.01) and between a higher level of AARC losses and poorer emotional (r = −.31; 95% CI −0.38, −0.24; p < .001; I2 = 0.00) and physical well-being (r = −.38; 95% CI −0.51, −0.24; p < .001; I2 = 83.48). We found a negligible association between AARC gains and physical well-being (r = .08; 95% CI 0.02, 0.14; p < .122; I2 = 0.00). Studies were of medium to high methodological quality. Discussion and Implications: There is some indication that AARC gains and losses can play a role in emotional well-being and that AARC losses are associated with physical well-being. However, the number of included studies is limited and there was some indication of heterogeneity. PROSPERO Registration: CRD42018111472.

21 May 2020 in Blood Advances
Verified
Journal Article
Open access
PDF file
SYSara Yumeen
Sara Yumeen
FMFatima N. Mirza
Fatima N. Mirza
JLJulia M. Lewis
Julia M. Lewis
AKAmber Loren O. King
Amber Loren O. King
SKSa Rang Kim
Sa Rang Kim
MGMichael Girardi
Michael Girardi
Cutaneous T-cell lymphoma (CTCL) is a malignancy of skin-homing T lymphocytes that is more likely to involve the peripheral blood in advanced stages. For such patients with advanced disease, there are few available systemic treatment options, and prognosis remains poor. Exome sequencing studies of CTCL have suggested therapeutic targets, including within the JAK/STAT pathway, but JAK inhibition strategies may be limited by patient-specific mutational status. Because our recent research has highlighted the potential roles of single and combination approaches specifically using BCL2, bromodomain and extra-terminal domain (BET), and histone deacetylase (HDAC) inhibition, we aimed to investigate the effects of JAK inhibition on CTCL cells and established CTCL cell lines when paired with these and other targeting agents. Peripheral blood malignant CTCL isolates exhibited differential responses to JAK inhibition, with JAK2 expression levels negatively correlating to 50% inhibitory concentration (IC50) values. Regardless of single-agent sensitivity, JAK inhibition potentiated malignant cell cytotoxicity in combination with BCL2, BET, HDAC, or proteasome inhibition. Combination inhibition of JAK and BCL2 showed the strongest potentiation of CTCL cytotoxicity, driven by both intrinsic and extrinsic apoptosis pathways. JAK inhibition decreased expression of BCL2 in the high-responder samples, suggesting a putative mechanism for this combination activity. These results indicate that JAK inhibition may have major effects on CTCL cells, and that combination strategies using JAK inhibition may allow for more generalized cytotoxic effects against the malignant cells from patients with CTCL. Such preclinical assessments help inform prioritization for combination targeted drug approaches for clinical utilization in the treatment of CTCL.

1 June 2019 in JAAD Case Reports
Verified
Journal Article
Open access
SKSa Rang Kim
Sa Rang Kim
NKNour Kibbi
Nour Kibbi
BCBrittany G. Craiglow
Brittany G. Craiglow

9 February 2023 in JID Innovations
Verified
Journal Article
Open access
JCJennifer S. Chen
Jennifer S. Chen
MMMichael J. Murphy
Michael J. Murphy
KSKatelyn Singh
Katelyn Singh
AWAlice Wang
Alice Wang
RCRyan D. Chow
Ryan D. Chow
WDWilliam Damsky
William Damsky
Acral dermatoses, including hyperkeratotic palmoplantar eczema (HPE), palmoplantar psoriasis (PP), and mycosis fungoides palmaris et plantaris (MFPP), can be challenging to diagnose clinically and histopathologically. In this setting, cytokine biomarkers may be able to help provide diagnostic clarity. Therefore, we evaluated IL-17A, IFN-γ, and IL-13 expression in PP, HPE, and MFPP and compared their expression profiles with nonacral sites. We used biopsy specimens from the Yale Dermatopathology database, selecting cases of HPE (n = 12), PP (n = 8), MFPP (n = 8), normal acral skin (n = 9), nonacral eczema (n = 10), and nonacral psoriasis (n = 10) with classic clinical and histopathologic features. IL17A mRNA expression by RNA in situ hybridization differentiated PP (median score 63.1 [interquartile range 9.4–104.1]) from HPE (0.8 [0–6.0]; P = 0.003), MFPP (0.6 [0–2.6]; P = 0.003), and normal acral skin (0 [0–0]; P < 0.001). Unexpectedly, both PP and HPE showed co-expression of IFNG and IL13 mRNA. In contrast, nonacral psoriasis and eczema showed divergent patterns of IFNG and IL13 mRNA expression. Taken together, we show that IL17A mRNA expression may be a useful biomarker of PP, and we further show that acral dermatoses exhibit distinct immunology compared to nonacral sites, with implications for clinical management.

1 October 2022 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
SKSa Rang Kim
Sa Rang Kim
JMJennifer M. McNiff
Jennifer M. McNiff
CKChristine J. Ko
Christine J. Ko

1 January 2021 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
FMFatima N. Mirza
Fatima N. Mirza
SYSara Yumeen
Sara Yumeen
JLJulia M. Lewis
Julia M. Lewis
AKAmber Loren O. King
Amber Loren O. King
SKSa Rang Kim
Sa Rang Kim
MGMichael Girardi
Michael Girardi